Project Details
Short title | A randomized, parallel group, open-label, active controlled, multicenter Phase III trial of Patupilone (EP0906) versus pegylated liposomal doxorubicin (Doxil/Caelyx) in taxane/platinum refractory/resistant patients with recurrent epithelial |
---|---|
Status | Finished |
Effective start/end date | 1/06/07 → 31/12/11 |
Funding
- Sandwell & West Birmingham Hospitals